The new year is off to a strong start for Monsanto as the Bayer unit heads into its second trial over allegations that its Roundup and other glyphosate-based herbicides cause cancer. In a Jan. 3 ruling, U.S. District Judge Vince Chhabria rejected arguments by attorneys representing cancer victims and sided with Monsanto in deciding to … New Year Off to a Strong Start for Monsanto
(Transcript of today’s proceedings) (See exclusive video interview with plaintiff Edwin Hardeman and his attorneys) The second Roundup cancer trial concluded Wednesday with a unanimous jury verdict that ordered Monsanto to pay roughly $80 million in damages for failing to warn plaintiff Edwin Hardeman of the cancer risks of Roundup herbicide. The jury verdict included … Verdict Is In – Monsanto Must Pay Cancer Victim $80 Million
( Transcript of today’s proceedings) Plaintiff Edwin Hardeman took the stand today to offer more testimony in his lawsuit against Monsanto over claims his use of the company’s Roundup herbicide caused him to develop non-Hodgkin lymphoma. Hardeman already testified in the first phase of the trial, which drew a unanimous jury verdict finding that Roundup … Cancer Victim Headed Back to the Stand
Bayer AG, which bought Monsanto last summer, said Monday that it was making scientific studies available for public scrutiny in an effort to counter growing concerns about the safety of Monsanto’s flagship glyphosate-based herbicide products. “Transparency is a catalyst for trust, so more transparency is a good thing for consumers, policymakers and businesses, Liam Condon, … Bayer Makes Bid for “Trust” Amid Third Monsanto Cancer Trial
